A second wave of COVID-19 is experienced in many countries. As of October 27, 2020, a total of 2,797 COVID-19 cases in IBD patients were reported in SECURE-IBD, paralleling this rise in COVID-19.
Please continue to spread the word about SECURE-IBD to all of your colleagues, locally, nationally, and internationally!
What is SECURE-IBD? Surveillance Epidemiology of Coronavirus) Under Research Exclusion (SECURE-IBD) is an international, pediatric and adult registry to monitor and report on outcomes of COVID-19 occurring in IBD patients. The registry contains only de-identified data.
How can a provider report a case? We encourage all IBD providers to report all cases of confirmed COVID-19 in IBD patients, regardless of severity. Reporting should take at most 5 minutes. Please report only confirmed COVID-19 cases, and report after a minimum of 7 days from COVID diagnosis and sufficient time has passed to observe the disease course through resolution of acute illness or death. To report a case of coronavirus, click here
Who is organizing this project? This project is being led by Drs. Michael Kappelman (Pediatric Gastroenterologist) and Erica Brenner (Pediatric Gastroenterology fellow) at the University of North Carolina at Chapel Hill and Dr. Ryan Ungaro (Gastroenterologist), Dr. Manasi Agrawal (Gastroenterologist) and Dr. Jean-Frederic Colombel (Gastroenterologist) at the Icahn School of Medicine at Mount Sinai, New York.
All information on the latest update: SECURE-IBD update #18